Inhibitory effects of anti-miRNA oligonucleotides (AMOs) on A549 cell growth

Journal of Drug Targeting

Volumn 16, Issue 9, 2008, Pages 688-693

  Fei, Jia ^a   Lan, Feiei ^a   Guo, Ming ^a   Li, Yumin ^a   Liu, Yu ^a  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

A549; Antisense oligonucleotide; Apoptosis; Cell growth; Drug targeting; MicroRNA

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MICRORNA; TRYPAN BLUE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG DESIGN; DRUG SYNTHESIS; DRUG TARGETING; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; MICRORNAS; OLIGONUCLEOTIDES;

EID: 55849092497     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860802295946     Document Type: Article

References (30)

1. Ambros, V. (2004) The functions of animal microRNAs. Nature, 431:7006, pp. 350-355.
2. Bartel, DP (2004) MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell, 116:2, pp. 281-297.
3. Blower, PE, Chung, JH and Verducci, JS (2008) MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther, 7:1, pp. 1-9.
4. Bottoni, A., Piccin, D. and Tagliati, F. (2005) miR-15a and miR-16-1 down-regulation in pituitary adenomas. J Cell Physiol, 204, pp. 280-285.
5. Calin, GA and Croce, CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer, 6:11, pp. 857-866.
6. Calin, GA and Croce, CM (2006) MicroRNA-cancer connection: The beginning of a new tale. Cancer Res, 66:15, pp. 7390-7394.
7. Calin, GA, Pekarsky, Y. and Croce, CM (2007) The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. Best Pract Res Clin Haematol, 20:3, pp. 425-437.
8. Chan, JA, Krichevsky, AM and Kosik, KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res, 65, pp. 6029-6033.
9. Chen, CZ, Li, L. Lodish, HF et al. (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science, 303:5654, pp. 83-86.
10. Cheng, AM, Byrom, MW and Shelton, J. (2005) Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res, 33:4, pp. 1290-1297.
11. Cimmino, A., Calin, GA Fabbri, M. et al. (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA, 102, pp. 13944-13949.
12. Davis, S., Lollo, B. and Freier, S. (2006) Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res, 34:8, pp. 2294-2304.
13. Debernardi, S., Skoulakis, S. Molloy, G. et al. (2007) MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia, 21:5, pp. 912-916.
14. Eder, M. and Scherr, M. (2005) MicroRNA and lung cancer. N Engl J Med, 352:23, pp. 2446-2448.
15. Esau, CC (2008) Inhibition of microRNA with antisense oligonucleotides. Methods, 44:1, pp. 55-60.
16. Esquela-Kerscher, A. and Slack, FJ (2006) Oncomirs-MicroRNAs with a role in cancer. Nat Rev Cancer, 6:4, pp. 259-269.
17. Garzon, R., Pichiorri, F. Palumbo, T. et al. (2007) MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene, 26, pp. 4148-4157.
18. Geary, RS, Watanabe, TA and Truong, L. (2001) Pharmacokinetic properties of 2′-O-(2-methoxyethyl)-modified oligonucleotide analogs in rats. J Pharmacol Exp Ther, pp. 890-897.
19. Griffiths-Jones, S., Grocock, RJ van Dongen, S. et al. (2006) miRBase: MicroRNA sequences, targets and gene nomenclature. Nucleic Acids Res, 34, pp. D140-D144.
20. He, L. and Hannon, GJ (2004) MicroRNAs: Small RNAs with a big role in gene regulation. Nature Rev Genet, 5:7, pp. 522-531.
21. Jay, C., Nemunaitis, J., Chen, P., Fulgham, P. and Tong, AW (2007) miRNA profiling for diagnosis and prognosis of human cancer. DNA Cell Biol, 6:5, pp. 293-300.
22. Krutzfeldt, J., Rajewsky, N. and Braich, R. (2005) Silencing of microRNAs in vivo with 'antagomirs'. Nature, 438:7068, pp. 685-689.
23. Lu, Z., Liu, M. Stribinskis, V. et al. (2008) MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene
24. Nana-Sinkam, SP and Geraci, MW (2006) MicroRNA in lung cancer. J Thorac Oncol, 1:9, pp. 929-931.
25. Takamizawa, J., Konishi, H. and Yanagisawa, K. (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res, 64:11, pp. 3753-3756.
26. Weiler, J., Hunziker, J. and Hall, J. (2005) Anti-miRNA oligonucleotides (AMOs): Ammunition to target miRNAs implicated in human disease?. Gene Ther, 13:6, pp. 496-502.
27. Yang, H., Kong, W. He, L. et al. (2008) MicroRNA expression profiling in human ovarian cancer: MiR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res, 68:2, pp. 425-433.
28. Yu, ZB, Jian, ZF and Shen, SH (2007) Global analysis of microRNA target gene expression reveals that miRNA targets are lower expressed in mature mouse and Drosophila tissues than in the embryos. Nucleic Acids Res, 35:1, pp. 152-164.
29. Yu, SL, Chen, HY and Chang, GC (2008) MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell, 13:1, pp. 48-57.
30. Zhu, S., Wu, H. Wu, F. et al. (2008) MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res, 8:3, pp. 350-359.